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Abstract 
Data on the respiratory burst activity of granulocytes from healthy and preeclamptic women 
have remained contradictory. To investigate the role of reactive oxygen species in the etiology 
of preeclampsia we measured superoxide anion generation by granulocytes from non-
pregnant, healthy, and preeclamptic women. We also examined the reciprocal effects of heat-
inactivated and non-inactivated plasma on superoxide production. Superoxide generation was 
measured by ferricytochrome-c reduction. Superoxide production induced by either phorbol-
12.13-dibutirate or N-formyl-methionyl-leucyl-phenylalanine was significantly decreased in 
granulocytes from normal pregnant women compared with non-pregnant and preeclamptic 
women. The phorbol-12.13-dibutirate-induced superoxide generation by granulocytes from 
non-pregnant and preeclamptic women was significantly inhibited by plasma from healthy 
pregnant women. The N-formyl-methionyl-leucyl-phenylalanine-stimulated superoxide 
production by granulocytes from non-pregnant and preeclamptic women was suppressed only 
by non-inactivated plasma, not heat-inactivated plasma from healthy pregnant women. Plasma 
from preeclamptic women did not influence the phorbol-12.13-dibutirate- and N-formyl-
methionyl-leucyl-phenylalanine-induced superoxide production by control granulocytes. The 
phorbol-12.13-dibutirate-induced superoxide generation by granulocytes from healthy 
pregnant women was significantly increased by the effect of plasma from non-pregnant and 
preeclamptic women, but when stimulating with N-formyl-methionyl-leucyl-phenylalanine 
only non-inactivated plasma caused the same enhancement. These data indicate that reduced 
superoxide generation in normal pregnancy may be caused by maternal immunosuppressive 
factors present in plasma. The failure to reduce superoxide production in preeclampsia may be 
partly responsible for the endothelial dysfunction characteristic of that condition. 
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1. Introduction  
Preeclampsia is a pregnancy-specific multisystem disorder that develops in 3–10% of 
human pregnancies and is the leading cause of maternal and perinatal morbidity and 
mortality, especially in developed countries (Davey and MacGillivray, 1988). It is 
characterized by an abnormal vascular response to placentation, resulting in mild to severe 
maternal hypertension, proteinuria, enhanced platelet aggregation and activation of the blood 
coagulation system (Sibai et al., 2005). In addition to genetic factors maternal endothelial cell 
damage and dysfunction have been proposed to be implicated in the pathogenesis of the 
disease (Mellembakken et al., 2002). Although the exact mechanism is not yet known, an 
excessive maternal inflammatory response to pregnancy and the activation of granulocytes by 
placentally released circulatory factors have been suggested to contribute to endothelial 
damage in preeclampsia (Aly et al., 2004). Interaction of these factors with granulocytes may 
induce the production of superoxide anions (O2
.-
) and related reactive oxygen species (ROS) 
(Hubel, 1999). Superoxide anions generated by activated granulocytes may initiate oxidative 
stress, lipid peroxidation and endothelial cell lysis (Gratacós, 2000).  
Studies on O2
.-
 production by granulocytes from normal and preeclamptic women have 
also provided conflicting results. The data published by Tsukimori et al. (1993) demonstrated 
that N-formyl-methionyl-leucyl-phenylalanine (FMLP)-stimulated O2
.-
 generation by 
granulocytes was increased in women with preeclampsia compared with healthy pregnant 
women, and no significant difference was found between O2
.-
 production by granulocytes 
from normal pregnant women and that by granulocytes from healthy non-pregnant women. 
Selvaraj et al. (1982) showed a higher granulocyte O2
.-
 level in normal pregnancy compared 
with non-pregnant controls. Sacks et al. (1998) measured an increasing oxygen radical 
production of granulocytes in normal pregnancy and preeclampsia, but were unable to 
demonstrate a significant difference between these groups. In contrast, Crocker et al. (1999; 
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2000) reported that the FMLP-induced granulocyte O2
.-
 generation was significantly reduced 
in healthy pregnant women compared with non-pregnant  controls, and they found no 
significant difference between O2
.- 
generation by granulocytes from patients with 
preeclampsia and granulocytes from healthy non-pregnant women. Crouch et al. (1995) and 
others have shown significantly lower granulocyte O2
.-
 production in healthy pregnant women 
compared with non pregnant controls (Miller and Russell, 1986).  
Several circulatory factors can influence O2
.-
 production in normal and preeclamptic 
pregnancies (Redman and Sargent, 2003).  There are suppressive effects in the maternal 
immune system in normal pregnancy; therefore, it is reasonable to suppose that 
immunosuppressive factors may also be present in the circulation of the mother (Viganò et al., 
2007). For this reason the reduced O2
.-
 generation in healthy pregnancy and normal O2
.-
 
production in women with preeclampsia may be due to the presence and absence of these 
factors in the plasma of normal and preeclamptic women, respectively. The purpose of our 
current study was to test this hypothesis. Therefore, we aimed to examine reciprocally 
whether plasma samples from healthy non-pregnant, normal and preeclamptic women could 
influence the phorbol-12,13-dibutirate- (PDBu) and FMLP-induced O2
.- 
production by 
granulocytes from non-pregnant controls, and healthy and preeclamptic women. Furthermore, 
the O2
.- 
production by granulocytes from healthy non-pregnant, normal and preeclamptic 
women was also measured using the above-mentioned stimulating agents.  
 
2. Materials and methods 
2.1. Study population 
After informed consent and the approval of the Institutional Ethics Committee, 
peripheral blood was collected from 31 normal and 39 preeclamptic women in their third 
trimester of pregnancy. Blood samplings were performed in gestational weeks 26–38. A 
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group of 35 age-matched non-pregnant women served as controls in this study. Preeclampsia 
was defined as development of hypertension after the 20
th
 week of pregnancy ( 140/90 mm 
Hg measured in two consecutive occasions 6 hours apart) and proteinuria of higher than 300 
mg/day. The preeclamptic group included 9 mildly and 30 moderately ill patients with blood 
pressure of 140/90–149/99 mm Hg and 150/100–159/109 mm Hg, respectively (ACOG 
Committee on Obstetric Practice, 2002). All of the patients with preeclampsia were not on 
any medication, without a history of diabetes mellitus and with an absence of major medical 
disease or surgical intervention.  
 
2.2 Separation of granulocytes from peripheral blood 
Peripheral blood was collected in vacutainer test tubes containing EDTA (Becton-
Dickinson, Cedex, France). Blood samples were layered on the top of a Ficoll solution (1.077 
g/mL) and the supernatant containing the leukocytes was removed after sedimentation of 
erythrocytes at 1 g for 60 min at room temperature. The leukocyte-rich plasma was layered on 
top of a discontinuous Ficoll gradient (1.077 and 1.119 g/mL) and centrifuged at 350 g at 
20C for 30 min. Granulocytes sedimented at the interface of the Ficoll layers were collected 
and washed twice with Hanks’ solution, pH 7.4 at 20C (English and Andersen, 1974). Cell 
viability checked by the trypan blue exclusion test was found to be 98%. The purity of the 
granulocyte suspensions varied between 94 and 98% as revealed by microscopic 
examinations. Red blood cells were not removed by hypotonic lysis since the erythrocyte 
contamination in the granulocyte suspensions was negligible.    
 
2.3. Measurement of superoxide anion production 
Superoxide anion release was measured by superoxide dismutase-inhibitable (SOD, 
from bovine erythrocytes, 4200 U/mg protein) reduction of ferricytochrome-c (Babior et al., 
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1975). Granulocytes (3x10
5) were incubated in Hanks’ solution (pH 7.4) with phorbol-12,13-
dibutyrate (PDBu) or n-formyl-methionyl-leucyl-phenylalanine (FMLP) at 37C for 15 min. 
The total assay volume was 0.5 mL. The final concentrations of SOD, ferricytochrome-c, 
PDBu, and FMLP were 100 U/mL, 50 mol/L, 100 nmol/L, and 1 mol/L, respectively. The 
change in absorbance was measured spectrophotometrically at 550 nm with a double beam 
Shimadzu UV-160A spectrophotometer (Shimadzu Seisakusho Ltd., Kyoto, Japan) at room 
temperature. The amount of superoxide anion secreted into the medium was calculated on the 
basis of the molar extinction coefficient of reduced cytochrome-c 2.1x10
4
 M
-1
cm
-1
 (Pick and 
Keisari, 1981).  
 
2.4. Effect of plasma samples on superoxide anion production by granulocytes from non-
pregnant, healthy pregnant, and preeclamptic women  
Plasma fractions were isolated from peripheral blood of healthy non-pregnant and 
normal pregnant women as well as patients with moderate preeclampsia by centrifugation at 
800 g at 20C for 10 min and then the plasma samples were divided into two parts. To check 
the suggested effect of the complement system on the superoxide production of granulocytes 
(Rossi, 1986) inactivated and non-inactivated plasma samples were used. Half of each 
fraction was heated to 56C for 30 min, while the other portion was not inactivated. 
Subsequently, the individual plasma preparations were not pooled. Every experiment was 
performed with inactivated and non-inactivated plasma samples simultaneously. Granulocytes 
(3x10
6
) from healthy non-pregnant women were incubated with plasma samples (1.5 ml) from 
normal and preeclamptic women. Granulocytes (3x10
6
) from normal pregnant women were 
treated with plasma preparations (1.5 ml) from healthy non-pregnant and preeclamptic 
women.  Granulocytes (3x10
6
) from preeclamptic women were incubated with plasma 
fractions (1.5 ml) of non-pregnant and healthy pregnant women. In order to examine the 
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possibility of stimulation or suppression of O2
.- 
production due to an immune reaction of the 
cells with foreign plasma factors, granulocytes (3x10
6
) from non-pregnant, healthy pregnant, 
and preeclamptic women were also treated with autologous and heterologous plasma samples 
(1.5 ml) of non-pregnant, normal, and preeclamptic women respectively. Following 
incubation of the cells at 37C for 1 h, granulocytes were washed with Hanks’ solution and 
O2
.- 
production was measured as described above.   
 
2.5. Statistical analysis 
The results are presented as means (SD). The distribution of data, checked by the 
Kolmogorov–Smirnov test, was normal. Differences among the clinical parameters of the 
study population, superoxide anion production by granulocytes from non-pregnant controls, 
normal pregnant women, and preeclamptic women as well as O2
.-
 generation by granulocytes 
from non-pregnant, healthy pregnant, and preeclamptic women treated with appropriate 
plasma samples were determined by one-way analysis of variance (ANOVA) using the 
Newman–Keuls post-hoc test. The data in Figs. 1-3 represent the mean values (SD) obtained 
from independent experiments with granulocytes and plasma samples isolated from six 
individual women per group. Values of p0.05 were considered to be statistically significant.   
 
3. Results  
The clinical parameters of the study population are presented in Table 1. There were 
significant differences in systolic and diastolic blood pressures (p<0.001), body mass index 
(BMI, p<0.05), gestational age at delivery (p<0.01), proteinuria at the time of blood sampling 
(p<0.001), and birth weight (p<0.01) between normal pregnant and preeclamptic women. 
 
3.1. Superoxide anion production by granulocytes 
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Superoxide anion production by granulocytes from healthy non-pregnant, normal 
pregnant, and preeclamptic women in response to PDBu and FMLP stimulation is illustrated 
in our previous work (Lampé et al., 2008). As shown there, using the two stimulator agents 
(PDBu and FMLP), granulocytes from normal pregnant women demonstrated significantly 
decreased O2
.-
 generation compared with non-pregnant and preeclamptic women. There was 
no significant difference in O2
.- 
production by granulocytes from non-pregnant controls and 
that by granulocytes from patients with preeclampsia. Granulocytes from preeclamptic 
women released a significantly greater amount of O2
.- 
compared with normal pregnant 
women.  
 
3.2. Effects of plasma samples on superoxide anion production  
The effects of plasma fractions from normal pregnant and preeclamptic women on O2
.-
 
production by granulocytes from healthy non-pregnant women are illustrated in Fig. 1A and 
1B. As shown in Fig. 1A, both inactivated plasma (IP) and non-inactivated plasma (NIP) from 
healthy pregnant women significantly inhibited the PDBu-induced O2
.-
 generation by 
granulocytes from non-pregnant controls compared with O2
.-
 generation by the cells treated 
with autologous and heterologous IP and NIP from healthy non-pregnant women as well as 
preeclamptic women. There were no significant differences in PDBu-stimulated O2
.-
 
generation by granulocytes from non-pregnant controls after incubation of the cells with 
autologous and heterologous plasma from non-pregnant women as well as plasma from 
preeclamptic women. As depicted in Fig. 1B, the FMLP-stimulated O2
.-
 production by 
granulocytes from non-pregnant controls was not influenced by IP from healthy pregnant and 
preeclamptic and heterologous non-pregnant women. However, incubation of the cells with 
NIP from healthy pregnant women resulted in a significant inhibition of O2
.-
 generation  
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compared with O2
.- 
production by granulocytes treated with autologous and heterologous  NIP 
from non-pregnant and preeclamptic women.  
The results of reciprocal plasma experiments with granulocytes from healthy pregnant 
women are demonstrated in Fig. 2. Both IP and NIP from healthy non-pregnant and 
preeclamptic women significantly increased the PDBu-induced O2
.-
 generation by 
granulocytes from normal pregnant women compared with O2
.-
  generation by granulocytes 
incubated with IP and NIP from autologous and heterologous healthy pregnant women (Fig. 
2A).   There were no significant differences in the PDBu-stimulated O2
.-
 generation following 
incubation of the cells with autologous and heterologous healthy pregnant plasma. IP from 
healthy non-pregnant and preeclamptic women as well as heterologous healthy pregnant 
women did not influence the FMLP-stimulated O2
.-
 production by granulocytes from normal 
pregnant women (Fig. 2B). In contrast, incubation of the cells with NIP from non-pregnant 
and preeclamptic women resulted in a significant increase in O2
.-
 generation compared with 
O2
.-
  production by granulocytes treated with autologous and heterologous NIP from healthy 
pregnant women.  
The effects of plasma fractions from non-pregnant controls and healthy pregnant 
women on O2
.- 
production by granulocytes from preeclamptic women are presented in Fig. 3. 
Treatment of the cells with IP and NIP from healthy pregnant women caused a significant 
decrease in the PDBu-induced O2
.-
 generation by granulocytes from patients with 
preeclampsia compared with O2
.- 
release by granulocytes incubated with autologous and 
heterologous IP and NIP from preeclamptic women (Fig. 3A). There were no significant 
differences in PDBu-stimulated O2
.-
 production following incubation of the cells with 
autologous  and heterologous preeclamptic plasma as well as non-pregnant plasma. Exposure 
of granulocytes from preeclamptic women to IP from non-pregnant, and autologous and 
heterologous preeclamptic women did not cause significant changes in the FMLP-stimulated 
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O2
.-
 generation (Fig. 3B). However, treatment of the cells with NIP from healthy pregnant 
women resulted in a significant reduction in O2
.-
 generation compared with O2
.- 
production by 
granulocytes incubated with autologous  and heterologous NIP from preeclamptic women.  
 
4. Discussion  
Data on the respiratory burst activity of granulocytes from healthy and preeclamptic 
women have remained contradictory.  Although numerous studies have reported that there is 
no significant difference between the stimulated O2
.- 
production by granulocytes from  non-
pregnant controls and that by granulocytes from healthy pregnant subjects (Tsukimori et al., 
1993), pregnancy-related depression of granulocyte ROS generation has also been reported by 
several researchers (Crouch et al., 1995; Miller and Russell, 1986; Kindzelskii et al., 2002, 
2004). In order to further investigate the involvement of granulocyte-derived free radicals in 
the endothelial injury in preeclampsia, we measured O2
.-
 production by granulocytes from 
non-pregnant controls, healthy women, and preeclamptic women. Our results suggest that one 
of the most important granulocyte functions, the generation of ROS, is suppressed in 
physiological pregnancy, which is consistent with the findings of previous studies 
demonstrating depression of granulocyte ROS generation in healthy pregnant women. This 
reduction may be explained by a general suppression of cell-mediated immunity that has been 
demonstrated in pregnancy (Terness et al., 2007). The attenuation of O2
.- 
production may be 
required to protect fetal and maternal cells from the granulocyte-mediated oxidative damage 
in normal pregnancy. A similar decrease in ROS generation was not detected in patients with 
preeclampsia, which may be due to disturbances in the maternal immune system and may be 
partly responsible for endothelial injury in preeclampsia.  
Epidemiological studies have supported the fact that the incidence of bacterial and 
viral infections is higher among pregnant women (Persellin and Thoi, 1979; Jamieson et al., 
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2006). As granulocyte-derived ROS play a pivotal role in the destruction of pathogenic micro-
organisms (Witko-Sarsat et al., 2000), our results and previous findings indicating decreased 
O2
.-
 generation in physiological pregnancy are in agreement with these epidemiological data. 
In addition, sera from pregnant women have been demonstrated to inhibit bacterial killing and 
phagocytosis by control granulocytes (Persellin and Leibfracth, 1978). Similarly, a suppressive 
effect of both IP and NIP from healthy pregnant women on the PDBu-induced O2
.-
 generation 
by granulocytes from non-pregnant controls and patients with preeclampsia was observed in 
our study. In contrast, depression of the FMLP-stimulated O2
.- 
production was not detected, 
when granulocytes from non-pregnant and preeclamptic women were incubated with IP from 
healthy pregnant women. This suggests that the plasma factor responsible for the suppression 
of FMLP-induced respiratory burst may be heat-sensitive and was therefore degraded during 
heating. To exclude this possibility, control and preeclamptic granulocytes were also treated 
with NIP from normal pregnant women. The results of these experiments indicated that NIP 
from healthy pregnant women was able to decrease the FMLP-stimulated O2
.-
 generation by 
granulocytes from non-pregnant and preeclamptic women. The inhibition was probably not 
associated with the effect of foreign plasma factors since there was no significant difference 
in the PDBu- and FMLP-stimulated O2
.-
 production by granulocytes  from normal and 
preeclamptic women after incubation of the cells with autologous and heterologous plasma 
samples. Our investigations also indicated that preeclamptic plasma did not increase PDBu- 
and FMLP-induced O2
.-
 generation by control granulocytes.  
To show that the depression of O2
.-
 production was mediated by the healthy pregnant 
plasma, granulocytes from normal pregnant women were incubated with plasma from non-
pregnant and preeclamptic women. The results of these experiments demonstrated that the 
decreased ROS generation by healthy pregnant granulocytes could be increased by treatment 
of the cells with non-pregnant and preeclamptic plasma. In the case of PDBu stimulation, both 
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IP and NIP samples were able to enhance the O2
.-
 production by healthy pregnant 
granulocytes. The FMLP-stimulated O2
.-
 production by normal pregnant granulocytes exposed 
to non-autologous and heterologous NIP was also improvable by treatment of the cells with 
NIP from non-pregnant and preeclamptic women. In response to FMLP, O2
.-
 production by 
granulocytes from normal pregnant women treated with autologous and heterologous IP 
samples showed a similar O2
.-
 release to granulocytes from healthy pregnant women treated 
with IP from non-pregnant and preeclamptic women. This finding also suggests that the 
healthy pregnant plasma factor responsible for the inhibition of FMLP-induced respiratory 
burst was inactivated during heating, and was therefore not able to suppress O2
.-
 generation.  
The mechanisms by which a plasma factor of healthy pregnant women can inhibit the 
O2
.- 
production by granulocytes from non-pregnant and preeclamptic women are not yet 
known. Our results suggest that the factor in question may affect the signal transduction 
pathways resulting in the activation and translocation of PKC from the cytosol to the plasma 
membrane. This has been reported to induce a sequence of events leading to the translocation 
of the cytosolic components of NADPH oxidase to the cell membrane and subsequently the 
assembly of the active O2
.- 
generating enzyme complex (Nauseef et al., 1991). The agonists 
used in our experiments can activate PKC in different pathways. Following binding to formyl 
peptide receptors (FPRs), FMLP has been shown to initiate the hydrolysis of 
phosphatidylinositol-4,5-bisphosphate, resulting in the production of inositol-1,4,5-
trisphosphate and diacylglycerol (DAG), which activates PKC (Panaro et al., 2006).  PDBu 
mimics the action of DAG, bypasses receptor-mediated signaling events and directly activates 
PKC (Goel et al., 2007). We suppose that the NIP factor might interact with FPRs, leading to 
a decrease in their ligand-binding capacity; therefore, the receptors might be less efficient in 
transducing signals required for the induction of O2
.-
 production. With heat treatment, the 
plasma factor in question appears to undergo denaturation that abolishes its ability to 
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influence receptor-mediated signaling. However, further studies are required to specify this 
factor. 
In conclusion, O2
.- 
production by granulocytes is decreased in normal pregnancy, which 
may be due to a defense mechanism to protect the maternal and fetal cells against granulocyte-
mediated oxidative damage. The deficient O2
.- 
generation in normal pregnancy may be caused 
by maternal immunosuppressive circulatory factors. The failure to reduce O2
.- 
production in 
preeclamptic women may be partly responsible for endothelial injury. However, further 
studies are required to confirm this conclusion. 
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Figure Legends  
 
Figure 1.  
Effect of plasma samples on PDBu- (A) and FMLP-stimulated (B) superoxide anion 
production by granulocytes from non-pregnant controls. Granulocytes were incubated with 
inactivated (IP) and non-inactivated (NIP) plasma from healthy and preeclamptic women as 
well as with autologous and heterologous non-pregnant plasma.  Mean values (SD) obtained 
from independent experiments with granulocytes and plasma samples isolated from six 
individual women/group are demonstrated. Significant differences are indicated as follows: 
***p < 0.001 autologous IP versus healthy pregnant IP;
 ##
p < 0.01, 
###
p < 0.001 autologous 
NIP versus NIP from healthy pregnant women.  
 
Figure 2.  
Effect of plasma samples on PDBu- (A) and FMLP-induced (B) superoxide anion production 
by granulocytes from healthy pregnant women. Granulocytes were incubated with inactivated 
(IP) and non-inactivated (NIP) plasma samples from non-pregnant controls and preeclamptic 
women as well as with autologous and heterologous plasma from normal pregnant subjects.  
Mean values (SD) obtained from independent experiments with granulocytes and plasma 
samples isolated from six individual women/group are presented. Significant differences are 
indicated as follows: ***p < 0.01 autologous IP versus healthy non-pregnant IP and 
preeclamptic IP;
 ###
p < 0.001 autologous NIP versus NIP from healthy non-pregnant and 
preeclamptic women.  
 
Figure 3.  
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Effect of plasma samples on PDBu- (A) and FMLP-stimulated (B) superoxide anion 
production by granulocytes from preeclamptic women. Granulocytes were incubated with 
inactivated (IP) and non-inactivated (NIP) plasma samples from non-pregnant controls and 
healthy pregnant subjects as well as with autologous and heterologous plasma from 
preeclamptic women.  Mean values (SD) obtained from independent experiments with 
granulocytes and plasma samples isolated from six individual women/group are shown. 
Significant differences are indicated as follows: *p < 0.05, ***p < 0.001 autologous IP versus 
healthy pregnant IP; 
###
p < 0.001  autologous NIP versus NIP from normal pregnant women.  
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Table 1. 
 
Clinical characteristics of non-pregnant (NP), healthy pregnant (HP), and preeclamptic 
pregnant (PE) women 
 
Clinical data 
NP women 
(n=35) 
HP women 
(n=31) 
PE women 
(n=39) 
p value 
Age (years)  31.6  2.8 31.1  4.3 31.3  3.9 0.05 
Gestational age at blood-
sampling (weeks)
 
 
NA 32.1  3.3 32.4  4.9 0.05 
Gestational age at 
delivery (weeks)
 
 
NA 40.0  1.4 37.4  2.3 <0.05* 
Pre-pregnancy BMI
b
 
(kg/m
2
)
 
 
NA 24.3  1.4 24.6  1.6 0.05 
BMI at blood sampling 
(kg/m
2
)
 
 
25.2  1.4 27.4  4.4 30.8  4.2 <0.05* 
Parity 
a
 NA 0 (0–2) 0 (0–1) 0.05 
Gravidity 
a
 NA 2 (1–3) 2 (1–3) 0.05 
Systolic blood pressure at 
blood sampling (mm Hg)
 
 
124  4.7 121  5.8 153  7.8 <0.05* 
Diastolic blood pressure 
at blood sampling (mm 
Hg)
 
 
80  4.6 79  6.5 104  4.1 <0.05* 
Neonatal weight (g)
 
 NA 3533.1  538 3008  736 <0.05* 
Proteinuria at blood 
Sampling, urine dipstick 
a
 
0 (0–0) 0 (0–0) 3 (1–3+) <0.05* 
 
Mean values   SD are presented. aValues are expressed as median (range). NA: not 
applicable. Significant differences are indicated as follows: *p<0.05 healthy pregnant versus 
preeclamptic pregnant women, 
b
BMI: body mass index 
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Figure 3.  
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